NRG Energy, Inc.
NRG Energy, Inc. Sends Letter to NRG Stockholders
Published in Law and Health Weekly, April 25th, 2009
NRG Energy, Inc. (NYSE: NRG) today filed its preliminary proxy statement and sent the following letter to NRG stockholders regarding Exelon Corporation’s (NYSE: EXC) attempt to expand NRG’s Board of Directors from its current 13 directors to 19 directors and elect a slate of its nine directors to NRG’s Board of Directors, all to impose on NRG’s stockholders its wholly inadequate, highly conditional and risky unsolicited proposal to acquire NRG by means of its offer to exchange 0.485 of its shares for each share of NRG stock.
April 2, 2009
Keywords: NRG Energy, Inc., Drugs, Exelon, Pharmaceuticals,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives Nasdaq Stockholder Equity Notification - Acacia Research Corporation
Acacia Subsidiary Licenses Medical Picture Archiving and Communication System PACS Technology to Siemens Medical Solutions - Addiction Research
Study results from University of Maryland in the area of addiction research published - adidas
adidas AG and adidas Canada File Suit - AIDS Healthcare Foundation
Thank You, Arnold, for Saving California AIDS Patients! - AirStrip Technologies, L.P.
AirStrip OB™ Receives FDA Clearance on BlackBerry™ - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
